Cyclin-Dependent Kinases (Cdk) as Targets for Cancer Therapy and Imaging

QR Code

Cyclin-Dependent Kinases (Cdk) as Targets for Cancer Therapy and Imaging

None

Saved in:

Bibliographic Details
Main Authors:	Graf, Franziska, Wuest, Frank, Pietzsch, Jens
Format:	Electronic Book Chapter
Language:	English
Published:	IntechOpen 2011
Subjects:	Health Sciences
Online Access:	https://www.intechopen.com/chapters/23922
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Cyclin-Dependent Kinase 5 – An Emerging Player in Parkinson’s Disease Pathophysiology
by: Cheung, Zelda H., et al.
Published: (2012)

Regulation of the G1/S Transition in Adult Liver: Expression and Activation of the Cyclin Dependent Kinase Cdk1 in Differentiated Hepatocytes is Controlled by Extracellular Signals and is Crucial for Commitment to DNA Replication
by: Pascal, Loyer, et al.
Published: (2011)

Hormone therapy for premenopausal women with metastatic breast cancer: combinations with cyclin-dependent kinase inhibitors
by: E. V. Artamonova, et al.
Published: (2019-09-01)

PRACTICAL ASPECTS OF ADMINISTERING CYCLIN-DEPENDENT KINASES INHIBITORS: EFFICACY AND TOLERABILITY
by: E. V. Artamonova
Published: (2018-04-01)

CYCLIN-DEPENDENT KINASE INHIBITOR, PALBOCICLIB – A NEW DRUG FOR THE TREATMENT OF METASTATIC BREAST CANCER
by: E. N. Imyanitov, et al.
Published: (2017-12-01)

Exploring the Therapeutic Potential of Antiaris africana: Targeting Cyclin-Dependent Kinases 8 and 13 for Cancer Treatment through Molecular Docking Studies
by: Mutiu A. Alabi, et al.
Published: (2025-06-01)

Cyclin-dependent kinase 1 targeting improves sensitivity to radiation in BRAF V600E colorectal carcinoma cells
by: Girolamo Spagnoletti, et al.
Published: (2018-04-01)

Faithful DNA Replication Requires Regulation of CDK Activity by Checkpoint Kinases
by: Sørensen, Claus Storgaard, et al.
Published: (2011)

Relationship between the Release of Interleukin 12 and the Expression of PCNA, Cyclin A2, and CDK2 in Lung Cancer Cells
by: Meliha Burcu IRMAK YAZICIOĞLU, et al.
Published: (2025-04-01)

MAP Kinases and Prostate Cancer
by: Rodríguez-Berriguete, Gonzalo, et al.
Published: (2011)

Spleen Tyrosine Kinase: A Novel Target in Autoimmunity
by: McAdoo, Stephen P., et al.
Published: (2012)

Current view of the inhibitor protein cyclin-dependent kinase р16, р27 and their role in the cell cycle
by: A. K. Aleksandrova, et al.
Published: (2016-02-01)

In Silico Characterization of a Cyclin Dependent Kinase -A (CDKA) and its Coding Gene in some Oryza Species
by: Ahmed Sayed Fouad, et al.
Published: (2020-07-01)

THE USE OF PALBOCKLIB, A CYCLINE-DEPENDENT KINASE 4/6 INHIBITOR, IN THE TREATMENT OF METASTATIC BREAST CANCER. A COST-CONSEQUENCE ANALYSIS
by: S. L. Pavlinsky, et al.
Published: (2017-09-01)

Efficacy of cyclin-dependent kinases 4 and 6 inhibitors in the treatment of HR +/HER2 − advanced breast cancer: a meta-analysis
by: Isah Adamu Danbala, et al.
Published: (2025-06-01)

CDK9 is a prognostic marker and therapeutic target in pancreatic cancer
by: Anna-Laura Kretz, et al.
Published: (2017-02-01)

Effectiveness of cyclin-dependent kinase 4 and 6 inhibitors for the treatment of hormonesensitive HER2-negative metastatic breast cancer in first-line therapy: A systematic literature review
by: N. A. Avxentyev, et al.
Published: (2024-05-01)

New Targets for Therapy in Pancreatic Cancer
by: Tinari, Nicola, et al.
Published: (2012)

Targeting EGFR and HER2 for Molecular Imaging of Cancer
by: Gong, Haibiao, et al.
Published: (2012)

Cancer Gene Therapy: The New Targeting Challenge
by: Touati, Walid, et al.
Published: (2011)

Targeting Tumor Microenvironments for Cancer Prevention and Therapy
by: Yang, Li V., et al.
Published: (2012)

Pharmacoeconomic analysis of using cyclin-dependent kinase 4 and 6 inhibitors in the first line treatment of HR-positive HER2-negative advanced breast cancer
by: N. A. Avxentyev, et al.
Published: (2020-02-01)

Muscle-Targeted Gene Therapy of Charcot Marie-Tooth Disease is Dependent on Muscle Activity
by: Klossner, Stephan, et al.
Published: (2011)

New Experimental Therapies Targetting Breast Cancer Cell
by: Melanie, Di Benedetto
Published: (2011)

The Potential Target Therapy of Prostate Cancer Stem Cells
by: Espinoza, Luis A., et al.
Published: (2011)

Cyclin-dependent kinase 5 negatively regulates antiviral immune response by disrupting myeloid differentiation primary response protein 88 self-association
by: Jian-Ping Ren, et al.
Published: (2023-12-01)

Immunoliposomes: A Multipurpose Strategy in Breast Cancer Targeted Therapy
by: Barrajón-Catalán, Enrique, et al.
Published: (2011)

miR-21-5p inhibitor enhances the radiosensitivity of human cervical cancer cells via blocking CPEB3-mediated CDK1/cyclin B pathway
by: Liang Jiao, et al.
Published: (2025-09-01)

Deletion of cyclin dependent kinase inhibitor 2a gene as a marker of oropharyngeal carcinomas non-associated with human papillomavirus and its prognostic value
by: I.S. Shponka, et al.
Published: (2024-06-01)

Protein Kinases and Ulcerative Colitis
by: Yan, Yutao
Published: (2011)

Suicide Gene Therapy by Herpes Simplex Virus-1 Thymidine Kinase (HSV-TK)
by: Dey, Dilip, et al.
Published: (2011)

Acute Promyelocytic Leukemia: A Model Disease for Targeted Cancer Therapy
by: Lång, Emma, et al.
Published: (2011)

Kinase Activity is Required for Growth Regulation but not Invasion Suppression by Syk Kinase in Pancreatic Adenocarcinoma Cells
by: Layton, Tracy, et al.
Published: (2012)

Distinct Pathologic Roles for Glycogen Synthase Kinase 3β in Colorectal Cancer Progression
by: Minamoto, Toshinari, et al.
Published: (2012)

Mitogen-Activated Protein Kinases and Mitogen-Activated Protein Kinase Phosphatases in Regenerative Myogenesis and Muscular Dystrophy
by: Shi, Hao, et al.
Published: (2012)

Targeted Therapies in Hematological Malignancies
by: Chalasani, Pavani, et al.
Published: (2011)

Choosing Targets for Gene Therapy
by: Matissek, Karina J., et al.
Published: (2011)

On the Specialization History of the ADP-Dependent Sugar Kinase Family
by: Merino, Felipe, et al.
Published: (2011)

Targeting Tumor Perfusion and Oxygenation Modulates Hypoxia and Cancer Sensitivity to Radiotherapy and Systemic Therapies
by: Jordan, Bénédicte F., et al.
Published: (2011)

Novel Chemoradiotherapy Regimens Incorporating Targeted Therapies in Locally Advanced Head and Neck Cancers
by: Rathore, Ritesh
Published: (2012)